# Thrivable

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thrivable

- Industry: Healthcare IT
- Headquarters: US
- Website: www.thrivable.app
- Total disclosed funding: $4.9M
- Latest round: Seed (Mar 24, 2023)
- Investors on record: 4

## About

Thrivable, Inc. is a U.S.-based company specializing in patient recruitment and market research services for the healthcare sector, utilizing advanced technology to streamline clinical trials and enhance patient engagement.Founded in 2019, Thrivable, Inc. operates primarily in the U.S. healthcare market, providing innovative solutions for patient recruitment. David Edelman serves as both the founder and CEO. The company has successfully completed 4 deals, with the most recent funding round occurring on March 24, 2023, where they raised USD 4.9 mn in Seed funding led by North Coast Ventures, alongside other investors including FCA Venture Partners, Jumpstart Ventures, and Tamarind Hill. This brings the total amount raised by Thrivable to USD 4.9 mn with a current company valuation of USD 15.71 mn.Thrivable specializes in providing a comprehensive suite of products and services designed to facilitate patient recruitment and market research within the healthcare sector. Their core offerings include access to a robust patient database that empowers clients to connect with vetted patients swiftly and efficiently, enhancing the speed and effectiveness of clinical trials. The platform is equipped with advanced technology that enables targeted recruitment strategies, ensuring high-quality data while maintaining security and compliance with privacy regulations. This service is particularly beneficial for healthcare organizations looking to streamline their research processes across various conditions such as diabetes, obesity, mental health, and heart disease. Thrivable serves a diverse client base that includes medical device manufacturers, clinical research organizations (CROs), and digital health companies, primarily within the U.S. market, though its services may extend to international clients as well.The revenue model for Thrivable is primarily structured around business-to-business (B2B) transactions, where clients pay for access to the patient recruitment platform and related research services. Clients typically engage in partnerships that may involve subscription agreements or project-based contracts, allowing them to leverage the patient database for their specific research needs. The pricing structure reflects the value of the comprehensive data and insights provided, with costs potentially varying based on the scope of services and the level of engagement required. Flagship offerings such as the TrendTracker Data Report and clinical research recruitment services are central to revenue generation, catering to organizations that seek timely and actionable patient insights. The company's approach to revenue generation emphasizes building long-term relationships with clients, ensuring consistent engagement and support throughout the research process.In March 2023, Thrivable, Inc. raised USD 4.9 mn in Seed funding, which will be used to enable healthcare organizations to swiftly gather patient data for product innovation. The company is focusing on enhancing its platform with upcoming product launches and expanding its reach into new geographic markets. Specific regions targeted for expansion include international markets, which will enhance Thrivable's client base and operational footprint. This strategic growth plan aims to leverage recent funding to support product development and market entry efforts.

## Funding rounds

- Seed, Mar 24, 2023, $4.9M — North Coast Ventures, Jumpstart Ventures, Tamarind Hill, FCA Venture Partners

## Investors

- North Coast Ventures (https://capitalatlas.ai/funds/north-coast-ventures) — Seed
- Jumpstart Ventures (https://capitalatlas.ai/funds/jumpstart-ventures) — Seed
- Tamarind Hill (https://capitalatlas.ai/funds/tamarind-hill) — Seed
- FCA Venture Partners (https://capitalatlas.ai/funds/fca-venture-partners) — Seed